By Sheeba M. | Thursday, June 11, 2026
Curated from social media posts and threads
Cannabis Market Surge: Trulieve NYSE Listing & Rescheduling Showdown
🚀 Market Movers
- Trulieve makes history: TRLV now trading on NYSE as first US plant-touching cannabis operator. Corporate restructuring separated US operations; historic milestone opens institutional investment door. Investor Update
- Verano prepares uplisting: Verano Holdings executing reverse stock split to meet exchange listing requirements, signals institutional confidence in upcoming U.S. stock exchange access.
- Tilray funds Lyphe acquisition: Tilray issued 1.6M shares (398k for UK clinic acquisition, 1.21M debt-for-equity exchange on June 3) retiring $6M of convertible notes. European medical expansion underway.
⚖️ Regulatory Watch
- Rescheduling faces court challenge: Drug testing organizations and pharma companies petitioned DC Circuit (June 9) to pause April’s Schedule III medical cannabis ruling. Claims $10M in FDA-regulated cannabis development now faces unfair competition from unlicensed state products.
- June 29 DEA hearing on broader rescheduling: Administrative hearing begins June 29, concludes by July 15, with potential decision by end of August. Recreational cannabis Schedule III reclassification could reshape entire industry. Major market event investors are monitoring closely.
- Virginia adult-use deal approaching: Gov. Spanberger reports “productive” budget negotiations with lawmakers on June 1 deadline for retail framework. Virginia has allowed possession/home grow since 2021; retail sales framework still missing—market opportunity ready to unlock.
🌍 International & Regional
- EU drug agency flags potency surge: EUDA 2026 report warns of decade-long cannabis potency increase across Europe. 25 million adults in European cannabis-using population; regulatory focus on product standards intensifying.
- Tilray launches premium German brand: Tilray Medical Germany introduces ARX premium cannabis brand (June 10) cultivated in Germany with rigorous quality standards targeting medical market expansion.
- Rhode Island restarts retail licensing: State restarts adult-use retail license processing after earlier pause; expansion of licensed retail framework continues across Northeast corridor.
📊 What Investors Should Watch
Next 30 Days: Trulieve trading stability on NYSE sets tone for sector credibility. Verano uplisting approval signals institutional readiness. Virginia deal closure (June 1) opens another state retail market. June 29 DEA hearing becomes flashpoint for broader rescheduling hopes.
Key Metrics: Monitor NYSE trading volume on TRLV for retail investor appetite. Track Schedule III legal challenges in DC Circuit. Watch Virginia legislature budget reconciliation for adult-use language. EU regulatory developments could shape international expansion opportunities.
Track the Companies
Monitor all major cannabis stocks with the Weedstock Real-Time Tracker—ticker prices, market cap, analyst ratings, and insider moves.
Sources
- Business of Cannabis — Daily market and regulatory news
- INN (Investing News Network) — Cannabis sector analysis
- Crowe & Dunlevy — Federal regulatory updates
- Marijuana Moment — State legalization tracking
- Cannabis Business Times — International developments